Literature DB >> 6885550

Flexure dose: the low-dose limit of effective fractionation.

S L Tucker, H D Thames.   

Abstract

Total radiation dose often can be increased without subsequent increases in the severity of tissue injury by using reduced doses per fraction. The flexure dose, df, is defined as the largest fractional dose for which further fractionation produces no significant change in the total dose required to reach a specified effect level. Thus, df is clinically relevant in that it represents the limit of effective dose fractionation. For those tissues in which injury reflects depletion of a critical proportion of target cells, the flexure dose is a measure of the extent of the initial, nearly linear portion of the dose-survival curve. More generally, the flexure dose is a measure of the extent of the initial, nearly linear portion of a dose-response curve in organized tissue, whatever its relationship to clonogenic target cells might be. Several quantitative expressions for df are derived. The characteristic common to these is that each defines the flexure dose as a multiple of the ratio alpha/beta of the parameters of the linear-quadratic model of cell survival or dose response, where the multiple is a measure of experimental or statistical resolution. These multiples tend to fall within a limited range, thereby defining the "region of flexure" via the inequality 0.05 (alpha/beta) less than or equal to df less than or equal to 0.15 (alpha/beta). Estimates of the region of flexure are presented for a variety of normal and neoplastic tissues.

Mesh:

Year:  1983        PMID: 6885550     DOI: 10.1016/0360-3016(83)90270-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  Comparison of isoeffect relationships in radiotherapy.

Authors:  E O Voit; P N Yi
Journal:  Bull Math Biol       Date:  1990       Impact factor: 1.758

2.  The linear quadratic fit for lung function after irradiation with X-rays at smaller doses per fraction than 2 Gy.

Authors:  C S Parkins; J F Fowler
Journal:  Br J Cancer Suppl       Date:  1986

3.  Phase II trial of chemotherapy, external and intraluminal radiation plus surgery for oesophageal cancer.

Authors:  J J Beitler; S Wadler; H Haynes; S Fell; A Rozenblit; E Wolf; B A Levine
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

Review 4.  The first James Kirk memorial lecture. What next in fractionated radiotherapy?

Authors:  J F Fowler
Journal:  Br J Cancer Suppl       Date:  1984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.